Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1992-04-13
1993-12-07
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
530828, A61K 3766
Patent
active
052681696
ABSTRACT:
A method of treating ovarian cancer in warm-blooded animals comprising intraperitoneally administering to warm-blooded animals by perfusion a recombinant polypeptide of human gamma interferon type with a specific activity at least equal to 1.times.10.sup.7 U/mg in an anti-cancer effective amount.
REFERENCES:
patent: 4650674 (1987-03-01), Aggarwai et al.
Seminars in Oncology, vol. 18, No. 3, Jun., 1991, pp. 248-254 Markman.
Proc-Am Soc Clin Oncol 9:156 (1990), Abstracts, Pujade et al.
Am J Clin Oncol, vol. 11, 1988, pp. 465-469, Welander et al.
D'Acquisto et al, Journal of Clinical Oncology vol. 6 No. 4 Apr. 1988, 689-695.
Saito et al, Cancer Chemother Pharmacol (1987), 19:233-239.
Brandely Maud
Lando Danielle
Roussel Uclaf
Schain Howard E.
LandOfFree
Treatment method of ovarian cancer using interferon gamma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment method of ovarian cancer using interferon gamma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment method of ovarian cancer using interferon gamma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2014400